After missing vaccine glory in pandemic, GSK looks to dominate other diseases.
While some states came to the global BIO 2023 convention in Boston on the hunt f...
The U.K. will launch a $50 million pilot program to explore how new weight-loss ...
An FDA advisory committee voted overwhelmingly to recommend approval of a monocl...
Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer's...
The House GOP wants to pursue hospital payment reforms that could cost hospitals...
Fifty years after a historic study on taurine, a new paper finds supplements of ...
In the latest edition of STAT's Health Tech newsletter: AI insight at BIO, Googl...
Pharma and biotech companies are increasingly using AI to discover and make medi...
FDA Commissioner Robert Califf told a crowd of biotech leaders at the BIO conven...
In high-income countries, such as the U.S., the rate of increase in BMI has actu...
It is never too early to think about the ethical issues that can arise from any ...
The recent rallying of Lilly’s market value has come as the result of two major ...
The FDA approval was supported by a double-blind, active comparator-controlled n...
The regulatory approval comes after a positive opinion issued by the European Me...
The company will now seek full-label approval for the bleeding reversal agent in...
